• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The development of transcatheter aortic valve replacement (TAVR).

作者信息

Cribier Alain

机构信息

Dept. of Cardiology, University of Rouen, France.

出版信息

Glob Cardiol Sci Pract. 2016 Dec 30;2016(4):e201632. doi: 10.21542/gcsp.2016.32.

DOI:10.21542/gcsp.2016.32
PMID:28979902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5624190/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/105dd905e0e7/gcsp-2016-4-e201632-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/1f15d86af7c6/gcsp-2016-4-e201632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/cd783ece956e/gcsp-2016-4-e201632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/e19f9a7f82e4/gcsp-2016-4-e201632-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/40f680f143b7/gcsp-2016-4-e201632-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/5c9e93b4ded4/gcsp-2016-4-e201632-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/2829fea7b7ed/gcsp-2016-4-e201632-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/08049edfa473/gcsp-2016-4-e201632-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/a062c0c53d16/gcsp-2016-4-e201632-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/336d176a7c3a/gcsp-2016-4-e201632-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/91fe6262847a/gcsp-2016-4-e201632-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/a80316132360/gcsp-2016-4-e201632-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/105dd905e0e7/gcsp-2016-4-e201632-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/1f15d86af7c6/gcsp-2016-4-e201632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/cd783ece956e/gcsp-2016-4-e201632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/e19f9a7f82e4/gcsp-2016-4-e201632-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/40f680f143b7/gcsp-2016-4-e201632-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/5c9e93b4ded4/gcsp-2016-4-e201632-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/2829fea7b7ed/gcsp-2016-4-e201632-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/08049edfa473/gcsp-2016-4-e201632-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/a062c0c53d16/gcsp-2016-4-e201632-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/336d176a7c3a/gcsp-2016-4-e201632-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/91fe6262847a/gcsp-2016-4-e201632-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/a80316132360/gcsp-2016-4-e201632-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd4/5624190/105dd905e0e7/gcsp-2016-4-e201632-g012.jpg

相似文献

1
The development of transcatheter aortic valve replacement (TAVR).经导管主动脉瓣置换术（TAVR）的发展
Glob Cardiol Sci Pract. 2016 Dec 30;2016(4):e201632. doi: 10.21542/gcsp.2016.32.
2
Exploring the Difference in Post-procedural Stroke Rates Between Patients with Aortic Stenosis Who Undergo Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement.探索接受经导管主动脉瓣置换术与外科主动脉瓣置换术的主动脉瓣狭窄患者术后中风发生率的差异。
Cureus. 2018 Apr 17;10(4):e2494. doi: 10.7759/cureus.2494.
3
Transcatheter aortic valve replacement in intermediate and low risk patients-clinical evidence.中低风险患者经导管主动脉瓣置换术——临床证据
Ann Cardiothorac Surg. 2017 Sep;6(5):493-497. doi: 10.21037/acs.2017.07.01.
4
Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).经导管主动脉瓣置换术与外科主动脉瓣置换术后出血并发症比较：来自 PARTNER I 试验（经导管主动脉瓣置入术）的见解。
J Am Coll Cardiol. 2014 Mar 25;63(11):1100-9. doi: 10.1016/j.jacc.2013.10.058. Epub 2013 Nov 27.
5
Ten-year experience with transcatheter and surgical aortic valve replacement in Finland.芬兰经导管主动脉瓣置换术和外科主动脉瓣置换术的 10 年经验。
Ann Med. 2019 May-Jun;51(3-4):270-279. doi: 10.1080/07853890.2019.1614657. Epub 2019 May 21.
6
Redo transcatheter aortic valve replacement in degenerated transcatheter bioprosthesis (TAV-in-TAV).再次行经导管主动脉瓣置换术治疗退行性经导管生物瓣（TAV-in-TAV）。
Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(10):703-712. doi: 10.1080/14779072.2023.2266368. Epub 2023 Oct 26.
7
Safety and efficacy of repeat transcatheter aortic valve replacement for the treatment of transcatheter prosthesis dysfunction.重复经导管主动脉瓣置换术治疗经导管假体功能障碍的安全性和疗效。
Expert Rev Med Devices. 2020 Dec;17(12):1303-1310. doi: 10.1080/17434440.2020.1848540. Epub 2020 Dec 31.
8
Feasibility of Transcatheter Aortic Valve Replacement in Prior Aortic Root Surgery: Insights From Virtual Modeling.既往主动脉根部手术后经导管主动脉瓣置换术的可行性：来自虚拟建模的见解
Circ Cardiovasc Interv. 2020 Nov;13(11):e009539. doi: 10.1161/CIRCINTERVENTIONS.120.009539. Epub 2020 Nov 2.
9
Transcatheter Aortic Valve Replacement for Failed Surgical or Transcatheter Bioprosthetic Valves: A Comprehensive Review.经导管主动脉瓣置换术治疗外科手术或经导管生物人工瓣膜功能障碍：综述
J Clin Med. 2024 Feb 25;13(5):1297. doi: 10.3390/jcm13051297.
10
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis.经导管主动脉瓣置换术治疗有症状的低危重度主动脉瓣狭窄患者。
J Am Coll Cardiol. 2018 Oct 30;72(18):2095-2105. doi: 10.1016/j.jacc.2018.08.1033. Epub 2018 Aug 28.

引用本文的文献

1
Emerging hybrid techniques in aortic valve interventions: A systematic review of integrating surgical and transcatheter approaches.主动脉瓣介入治疗中的新兴混合技术：手术与经导管方法整合的系统评价
Int J Health Sci (Qassim). 2025 Mar-Apr;19(2):66-77.
2
Sutureless Aortic Prosthesis Valves versus Transcatheter Aortic Valve Implantation in Intermediate Risk Patients with Severe Aortic Stenosis: A Literature Review.严重主动脉瓣狭窄中度风险患者中无缝合主动脉人工瓣膜与经导管主动脉瓣植入术的比较：文献综述
J Clin Med. 2024 Sep 20;13(18):5592. doi: 10.3390/jcm13185592.
3
Recent advancements in polymeric heart valves: From basic research to clinical trials.

本文引用的文献

1
A Prospective Analysis of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation.经股动脉导管主动脉瓣植入术后早期出院的前瞻性分析。
Am J Cardiol. 2016 Sep 15;118(6):866-872. doi: 10.1016/j.amjcard.2016.06.035. Epub 2016 Jun 27.
2
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.经导管主动脉瓣置换术与外科瓣膜置换术治疗中危患者的效果比较：倾向评分分析。
Lancet. 2016 May 28;387(10034):2218-25. doi: 10.1016/S0140-6736(16)30073-3. Epub 2016 Apr 3.
3
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.
聚合物心脏瓣膜的最新进展：从基础研究到临床试验。
Mater Today Bio. 2024 Aug 10;28:101194. doi: 10.1016/j.mtbio.2024.101194. eCollection 2024 Oct.
4
Alternative access in transcatheter aortic valve replacement-an updated focused review.经导管主动脉瓣置换术的替代入路——最新聚焦综述
Front Cardiovasc Med. 2024 Aug 8;11:1437626. doi: 10.3389/fcvm.2024.1437626. eCollection 2024.
5
Platelet Reduction after Transcatheter Aortic Valve Implantation: Results from the PORTRAIT Study.经导管主动脉瓣植入术后血小板减少：PORTRAIT研究结果
J Clin Med. 2024 Mar 10;13(6):1579. doi: 10.3390/jcm13061579.
6
Cost-utility analysis of TAVI compared with surgery in patients with severe aortic stenosis at low risk of surgical mortality in the Netherlands.荷兰低手术死亡风险的严重主动脉瓣狭窄患者中，经导管主动脉瓣植入术（TAVI）与外科手术的成本效用分析。
Cost Eff Resour Alloc. 2024 Mar 26;22(1):24. doi: 10.1186/s12962-024-00531-6.
7
TAVI in a Heart Transplant Recipient-Rare Case Report and Review of the Literature.心脏移植受者的经导管主动脉瓣植入术——罕见病例报告及文献综述
Biomedicines. 2023 Sep 26;11(10):2634. doi: 10.3390/biomedicines11102634.
8
Mild Paravalvular Leak May Pose an Increased Thrombogenic Risk in Transcatheter Aortic Valve Replacement (TAVR) Patients-Insights from Patient Specific In Vitro and In Silico Studies.轻度瓣周漏可能增加经导管主动脉瓣置换术（TAVR）患者的血栓形成风险——来自患者特异性体外和计算机模拟研究的见解
Bioengineering (Basel). 2023 Feb 1;10(2):188. doi: 10.3390/bioengineering10020188.
9
Visions of TAVR Future: Development and Optimization of a Second Generation Novel Polymeric TAVR.经导管主动脉瓣置换术未来愿景：第二代新型聚合物经导管主动脉瓣置换术的研发与优化。
J Biomech Eng. 2022 Jun 1;144(6). doi: 10.1115/1.4054149.
10
Improving transcatheter aortic valve interventional predictability via fluid-structure interaction modelling using patient-specific anatomy.通过使用患者特异性解剖结构的流固相互作用建模提高经导管主动脉瓣介入的可预测性。
R Soc Open Sci. 2022 Feb 9;9(2):211694. doi: 10.1098/rsos.211694. eCollection 2022 Feb.
经导管主动脉瓣置换术或外科主动脉瓣置换术治疗中危患者。
N Engl J Med. 2016 Apr 28;374(17):1609-20. doi: 10.1056/NEJMoa1514616. Epub 2016 Apr 2.
4
Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System.采用新型可重新护套的瓣上型自膨式经导管主动脉瓣系统治疗有症状的重度主动脉瓣狭窄。
JACC Cardiovasc Interv. 2015 Aug 24;8(10):1359-1367. doi: 10.1016/j.jcin.2015.05.015.
5
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.接受外科或自膨式经导管主动脉瓣置换术患者的 2 年结果。
J Am Coll Cardiol. 2015 Jul 14;66(2):113-21. doi: 10.1016/j.jacc.2015.05.017. Epub 2015 Jun 5.
6
European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.欧洲第二代 Edwards SAPIEN XT 经导管心脏瓣膜在重度主动脉瓣狭窄患者中的应用经验：SOURCE XT 注册研究的 1 年结果。
JACC Cardiovasc Interv. 2015 Apr 27;8(5):657-69. doi: 10.1016/j.jcin.2014.10.026.
7
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.经导管主动脉瓣置换术或主动脉瓣置换术治疗主动脉瓣狭窄高危患者的 5 年结果（PARTNER 1）：一项随机对照试验。
Lancet. 2015 Jun 20;385(9986):2477-84. doi: 10.1016/S0140-6736(15)60308-7. Epub 2015 Mar 15.
8
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial.经导管主动脉瓣置换术与外科主动脉瓣置换术治疗重度主动脉瓣狭窄患者的比较：来自所有患者的 NOTION 随机临床试验的 1 年结果。
J Am Coll Cardiol. 2015 May 26;65(20):2184-94. doi: 10.1016/j.jacc.2015.03.014. Epub 2015 Mar 15.
9
Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.经股动脉植入爱德华兹SAPIEN-XT人工心脏瓣膜后早期出院的可行性与安全性
Am J Cardiol. 2015 Apr 15;115(8):1116-22. doi: 10.1016/j.amjcard.2015.01.546. Epub 2015 Jan 31.
10
Transcatheter aortic-valve replacement with a self-expanding prosthesis.经导管主动脉瓣置换术采用自膨胀式人工瓣膜。
N Engl J Med. 2014 Sep 4;371(10):967-8. doi: 10.1056/NEJMc1408396.